See All Slides - tctmd.com

Slides

Presentation TCT 2015

What Is Optimal Prehospital Pharmacotherapy for STEMI in 2015?

Presenter: Timothy D. Henry, Philippe Gabriel Steg, Duane S. Pinto

October 11, 2015

Presentation TCT 2015

Assessment and Implications of Surgical Inoperability: Who Is at High Risk?

Presenter: Kevin J. Beatt, Craig R. Smith, Robert W. Yeh

October 11, 2015

Presentation TCT 2015

Bioresorbable Scaffolds in a Bifurcation During Primary PCI

Presenter: Mirvat Alasnag, Habib Gamra, Abdullah Shehab

October 11, 2015

Presentation TCT 2015

From PRAMI, CvLPRIT, and Other Studies to COMPLETE: What Answers Can We Expect (and Not Expect) From COMPLETE?

Presenter: Ori Ben-Yehuda, Ajay J. Kirtane, Shamir R. Mehta

October 11, 2015

Presentation TCT 2015

Two Primary PCI STEMI Cases With Cardiogenic Shock

Presenter: Martina Kelly Speight, Michael J. Lim

October 11, 2015

Presentation TCT 2015

Role of Bioresorbable Vascular Scaffolds in a Hybrid Revascularization Strategy

Presenter: Taehoon Ahn, Robert C. Welsh, Quang Ngoc Nguyen

October 11, 2015

Presentation TCT 2015

New Insights From the Stent for Life Initiative

Presenter: Timothy D. Henry, Philippe Gabriel Steg, Petr Kala

October 11, 2015

Presentation TCT 2015

Stents in CTO: If I Get It Open, Will It Stay Open?

Presenter: Etsuo Tsuchikane, Gerald S. Werner, Sunao Nakamura

October 11, 2015

Presentation TCT 2015

Functional Risk Scoring: Fame 3 and Beyond

Presenter: Kevin J. Beatt, Craig R. Smith, William F. Fearon

October 11, 2015

Presentation TCT 2015

Mechanisms and Predictors and Treatment of In-Stent Restenosis

Presenter: Soo-Jin Kang, Gary S. Mintz

October 11, 2015

Advertisement

Slides

What Is Optimal Prehospital Pharmacotherapy for STEMI in 2015?

Assessment and Implications of Surgical Inoperability: Who Is at High Risk?

Bioresorbable Scaffolds in a Bifurcation During Primary PCI

From PRAMI, CvLPRIT, and Other Studies to COMPLETE: What Answers Can We Expect (and Not Expect) From COMPLETE?

Two Primary PCI STEMI Cases With Cardiogenic Shock

Role of Bioresorbable Vascular Scaffolds in a Hybrid Revascularization Strategy

New Insights From the Stent for Life Initiative

Stents in CTO: If I Get It Open, Will It Stay Open?

Functional Risk Scoring: Fame 3 and Beyond

Mechanisms and Predictors and Treatment of In-Stent Restenosis

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content